Walgreens 2004 Annual Report Download - page 14

Download and view the complete annual report

Please find page 14 of the 2004 Walgreens annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 53

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53

14
Item 6. Selected Financial Data
Eleven-Year Summary of Selected Consolidated Financial Data
Walgreen Co. and Subsidiaries
(Dollars in Millions, except per share data)
(Restated - See Restatement Note on Pages 29-30)
Fiscal Year 2004 2003 2002 2001
Net Sales $37,508.2
$32,505.4
$28,681.1
$24,623.0
Costs and Deductions
Cost of sales 27,310.4
23,706.2
21,076.1
18,048.9
Selling, occupancy and
administration 8,071.7
6,967.9
5,998.7
5,193.1
Other income (1) 33.6
40.4
13.1
24.4
Total Costs and Deductions 35,348.5
30,633.7
27,061.7
23,217.6
Earnings
Earnings before income tax
provision and cumulative effect of
accounting changes 2,159.7
1,871.7
1,619.4
1,405.4
Income tax provision 809.9
706.6
611.3
530.6
Earnings before cumulative effect
of accounting changes 1,349.8
1,165.1
1,008.1
874.8
Cumulative effect of accounting
changes (2) -
-
-
-
Net Earnings $ 1,349.8
$ 1,165.1
$ 1,008.1
$ 874.8
Per Common Share (3)
Net earnings (2)
Basic $ 1.32
$ 1.14
$ .99
$ .86
Diluted 1.31
1.13
.98
.85
Dividends declared .18
.16
.15
.14
Book value 7.95
6.94
6.01
5.05
Non-Current Liabilities
Long-term debt $ 12.4
$ 9.4
$ 11.2
$ 20.8
Deferred income taxes 274.1
180.7
135.6
102.9
Other non-current liabilities 838.0
677.5
613.9
547.5
Assets and Equity
Total assets (4) $13,342.1
$11,656.8
$10,117.2
$ 9,042.3
Shareholders' equity 8,139.7
7,117.8
6,162.9
5,151.0
Return on average shareholders'
equity 17.7%
17.5%
17.8%
18.7%
Drugstore Units
Year-end: Units (5) 4,582
4,227
3,883
3,520